Invasive pulmonary aspergillosis in patients with influenza infection: Report of two cases and systematic review of the literature

Expert Review of Respiratory Medicine

Volumn 9, Issue 1, 2015, Pages 89-96

  Alshabani, Khaled ^a   Haq, Athar ^a   Miyakawa, Ryo ^b   Palla, Mohan ^a   Soubani, Ayman O ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b ST JOHN HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Aspergillosis; H1N1 influenza; infections; influenza; Outcome

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE; OSELTAMIVIR; VANCOMYCIN; VORICONAZOLE; ANTIFUNGAL AGENT; ANTIVIRUS AGENT;

ADULT; ASPERGILLUS FUMIGATUS; CASE REPORT; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FUNGUS CULTURE; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA A (H1N1); LUNG ASPERGILLOSIS; MIDDLE AGED; MIXED INFECTION; MORTALITY; PROGNOSIS; REVIEW; RISK FACTOR; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPERINFECTION; SYSTEMATIC REVIEW; DRUG EFFECTS; FATALITY; IMMUNOLOGY; INFLUENZA, HUMAN; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIVARIATE ANALYSIS; ORTHOMYXOVIRIDAE; PATHOGENICITY; RISK; TREATMENT OUTCOME; VIROLOGY;

ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; ASPERGILLUS FUMIGATUS; COINFECTION; COMORBIDITY; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFLUENZA, HUMAN; INVASIVE PULMONARY ASPERGILLOSIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; ORTHOMYXOVIRIDAE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84920996948     PISSN: 17476348     EISSN: 17476356     Source Type: Journal    
DOI: 10.1586/17476348.2015.996132     Document Type: Review

References (55)

1. Bhat N, Wright JG, Broder KR, et al. Influenza Special Investigations Team. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005;353:2559-67
2. Brundage JF. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006;6:303-12
3. Morens DM, Fauci AS. The 1918 influenza pandemic: insights for the 21st century. J Infect Dis 2007;195:1018-28
4. Fischer JJ, Walker DH. Invasive pulmonary aspergillosis associated with influenza. JAMA 1979;241:1493-4
5. McLeod DT, Milne LJ, Seaton A. Successful treatment of invasive pulmonary aspergillosis complicating influenza A. Br Med J (Clin Res Ed) 1982;285:1166-7
6. Lewis M, Kallenbach J, Ruff P, et al. Invasive pulmonary aspergillosis complicating influenza A pneumonia in a previously healthy patient. Chest 1985;87: 691-3
7. Urban P, Chevrolet JC, Schifferli J, et al. Invasive pulmonary aspergillosis associated with an acute influenza virus infection. Rev Mal Respir 1985;2:255-7
8. Kobayashi O, Sekiya M, Saitoh H. A case of invasive broncho-pulmonary aspergillosis associated with influenza A (H3N2) infection. Nihon Kyobu Shikkan Gakkai Zasshi 1992;30:1338-44
9. Bulpa P, Dive A, Delos M, et al. Invasive pulmonary aspergillosis and influenza virus infection in patients with chronic bronchitis? Rev Pneumol Clin 1995;51: 300-1
10. Alba D, Gomez-Cerezo J, Cobo J, et al. Invasive pulmonary aspergillosis associated with influenza virus. An Med Interna 1996;13:34-6
11. Boots RJ, Paterson DL, Allworth AM, Faoagali JL. Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. Thorax 1999;54:1047-9
12. Funabiki Y, Ishii K, Kusaka S, et al. Aspergillosis following influenza A infection]. Nihon Ronen Igakkai Zasshi 1999;36:274-8
13. Vandenbos F, Mondain-Miton V, Roger PM, et al. Invasive pulmonary aspergillosis during influenza: a fortuitous association? Presse Med 1999;28:1755
14. Matsushima H, Takayanagi N, Ubukata M, et al. Invasive pulmonary aspergillosis following influenza A infection. Nihon Kokyuki Gakkai Zasshi 2001;39:672-7
15. Lee FE, Daigle CC, Urban MA, et al. Fever and progressive respiratory failure in three elderly family members. Chest 2005;128: 1863-4
16. Hasejima N, Yamato K, Takezawa S, et al. Invasive pulmonary aspergillosis associated with influenza B. Respirology 2005;10: 116-19
17. Sugino K, Homma S, Takaya H, et al. Fatal invasive pulmonary aspergillosis triggered by influenza B virus infection in an individual with idiopathic pulmonary fibrosis. Nihon Kokyuki Gakkai Zasshi 2006;44:207-14
18. Ohnishi T, Andou K, Kusumoto S, et al. Two cases of successfully treated invasive pulmonary aspergillosis following influenza virus infection. Nihon Kokyuki Gakkai Zasshi 2007;45:349-55
19. Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis 2010;16:971-3
20. Helbig G, Woźniczka K, Wieczorkiewicz A, et al. Irreversible marrow aplasia after single course of 2-chlorodeoxyadenosine for hairy cell leukaemia preceding by A pandemic 2009-H1N1-associated pneumonia. Med Oncol 2011;28:1601-3
21. Adalja AA, Sappington PL, Harris SP, et al. Isolation of Aspergillus in three 2009 H1N1 influenza patients. Influenza Other Respi Viruses 2011;5:225-9
22. Passouant O, Mateu P, Commandini M, et al. Pulmonary aspergillosis in nonimmunocompromised patient with acute respiratory distress syndrome during A (H1N1) infection. Ann Fr Anesth Reanim 2011;30:e75-6
23. Vallero S, Carraro F, Fagioli F, et al. Influenza A (H1N1) in a pediatric patient with newly diagnosed acute promyelocytic leukemia and invasive pulmonary aspergillosis. J Pediatr Hematol Oncol 2011;33:562-4
24. Carfagna P, Brandimarte F, Caccese R, et al. Occurrence of influenza A(H1N1)v infection and concomitant invasive pulmonary aspergillosis in a patient with chronic obstructive pulmonary disease. Mycoses 2011;54:549-51
25. Igarashi A, Tokairin Y, Hirono O, et al. Two cases of mixed infection following 2009 H1N1 influenza pneumonia. Nihon Kokyuki Gakkai Zasshi 2011;49:226-31
26. Garcia-Vidal C, Barba P, Arnan M, et al. Invasive aspergillosis complicating pandemic influenza A (H1N1) infection in severely immunocompromised patients. Clin Infect Dis 2011;53:e16-19
27. Kim SH, Kim MN, Lee SO, et al. Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis. Mycoses 2012;55:189-92
28. Guervilly C, Roch A, Ranque S, et al. A strategy based on galactomannan antigen detection and PCR for invasive pulmonary aspergillosis following influenza A (H1N1) pneumonia. J Infect 2012;65:470-3
29. Wauters J, Baar I, Meersseman P, et al. Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective study. Intensive Care Med 2012;38:1761-8.
30. Hoyo-Ulloa I, Cobos-Trigueros N, Puig-de la Bellacasa J, Martńez-Martńez JA. Influenza A (H1N1) complicated by invasive aspergillosis in non-severely immunocompromised patients. Enferm Infecc Microbiol Clin 2012;30: 583-4
31. Otterspoor LC, Smit FH, van Laar TJ, et al. Prolonged use of extracorporeal membrane oxygenation combined with prone positioning in patients with acute respiratory distress syndrome and invasive Aspergillosis. Perfusion 2012;27: 335-7
32. Vehreschild JJ, Bröckelmann PJ, Bangard C, et al. Pandemic 2009 influenza A(H1N1) virus infection coinciding with invasive pulmonary aspergillosis in neutropenic patients. Epidemiol Infect 2012;140: 1848-52
33. Yildirim Y, Pecha S, Sill B, et al. Severe bacterial superinfection based on influenza A (H1N1) pneumonia in a heart-lung transplant recipient. Thorac Cardiovasc Surg 2013;61:255-7
34. Toh HS, Jiang MY, Tay HT. Invasive pulmonary aspergillosis in severe complicated influenza A. J Formos Med Assoc 2013;112:810-11
35. Kim MJ, Kim MK, Kang CK, et al. A Case of Acute Cerebral Aspergillosis Complicating Influenza A/H1N1pdm 2009. Infect Chemother 2013;45:225-9
36. Kwon OK, Lee MG, Kim HS, et al. Invasive pulmonary aspergillosis after influenza a infection in an immunocompetent patient. Tuberc Respir Dis (Seoul) 2013;75:260-3
37. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
38. Kousha M, Tadi R, Soubani AO. Pulmonary aspergillosis: a clinical review. Eur Respir Rev 2011;20:156-74.
39. Louria DB, Blumenfeld HL, Ellis JT, et al. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 1959;38:213-65
40. Bautista E, Chotpitayasunondh T, Gao Z, et al. Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 2010;362:1708-19.
41. Roilides E, Sein T, Roden M, et al. Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. J Infect Dis 2001;183:518-20
42. Astry CL, Jakab GJ. Influenza virus-induced immune complexes suppress alveolar macrophage phagocytosis. J Virol 1984;50: 287-92
43. Hartemink KJ, Paul MA, Spijkstra JJ, et al. Immunoparalysis as a cause for invasive aspergillosis? Intensive Care Med 2003;29: 2068-71
44. Kumar A, Zarychanski R, Pinto R, Cook DJ, et al. Canadian Critical Care Trials Group H1N1 Collaborative. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. JAMA 2009;302:1872-9
45. Brun-Buisson C, Richard JC, Mercat A, et al. REVA-SRLF A/H1N1v 2009 Registry Group. Early corticosteroids in severe influenza A/H1N1 pneumonia and acute respiratory distress syndrome. Am J Respir Crit Care Med 2011;183:1200-6.
46. Martin-Loeches I, Lisboa T, Rhodes A, et al. ESICM H1N1 Registry Contributors. Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med 2011;37:272-83
47. Samarakoon P, Soubani A. Invasive pulmonary aspergillosis in patients with COPD: a report of five cases and systematic review of the literature. Chron Respir Dis 2008;5:19-27
48. Perfect JR, Cox GM, Lee JY, Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis 2001;33:1824-33
49. Khasawneh F, Mohamad T, Moughrabieh MK, et al. Isolation of Aspergillus in critically ill patients: a potential marker of poor outcome. J Crit Care 2006;21:322-7
50. Soubani AO, Chandrasekar PH. The clinical spectrum of pulmonary aspergillosis. Chest 2002;121:1988-99
51. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985;157:611-14
52. Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004;170: 621-5
53. Dimopoulos G, Frantzeskaki F, Poulakou G, Armaganidis A. Invasive aspergillosis in the intensive care unit. Ann N Y Acad Sci 2012;1272:31-9
54. Falcone M, Massetti AP, Russo A, et al. Invasive aspergillosis in patients with liver disease. Med Mycol 2011;49:406-13
55. Herbrecht R, Denning DW, Patterson TF, et al. Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002;347:408-15